Tilray Brands, Inc. (TLRY) income statement
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3089% below fair value
$1.89−0.18 (-8.70%)
Close on Nov 20, 2026Market cap $279.32MP/E –Yield –
Tilray Brands, Inc. financial ratios
See a number that looks wrong?